Skyhawk Therapeutics


At Skyhawk Therapeutics we invent small molecules using proprietary kinetic, structural and computational models that correct RNA splicing and mis-spicing. Our small molecule platform accelerates drug development across a broad range of disease types.

Industries

Employees

51-200

Links


Org chart

Bill Haney
CEO & Chairman of the Board
Collapse
Terrance Connolly
Chief Operating Officer
John McKeague
Senior Vice President Legal
Maggie Beaudoin
VP Of Finance
Douglas V Faller
Chief Medical Officer
Kyle Dow
Vice President Corporate Development
Sergey Paushkin
Chief Scientific Officer
Joseph Duffy
Executive Vice President Of Medicinal Chemistry And CMC
Steven Taylor
Executive Vice President Business Development

Board & advisors



Offices